5.20 CONCURRENT ANTIPSYCHOTIC MEDICATION USE IN LOW-INCOME CHILDREN AND CHILDREN IN FOSTER CARE

2019 ◽  
Vol 58 (10) ◽  
pp. S251-S252
Author(s):  
William David Lohr ◽  
Yana Feygin ◽  
Kahir Jawad ◽  
Liza Creel ◽  
Jennifer F. Le ◽  
...  
Keyword(s):  
Foster Care ◽  
Antipsychotic Medication ◽  
Low Income ◽  
Medication Use ◽  
Low Income Children ◽  
Children In Foster Care

Age-Related Trends in Psychotropic Medication Use Among Very Young Children in Foster Care

2014 ◽  
Vol 65 (12) ◽  
pp. 1452-1457 ◽  
Author(s):  
Susan dosReis ◽  
Ming-Hui Tai ◽  
David Goffman ◽  
Sean E. Lynch ◽  
Gloria Reeves ◽  
...  
Keyword(s):  
Foster Care ◽  
Young Children ◽  
Psychotropic Medication ◽  
Medication Use ◽  
Children In Foster Care ◽  
Very Young Children ◽  
Age Related

scholarly journals High-level psychotropic polypharmacy: a retrospective comparison of children in foster care to their peers on Medicaid

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Deborah Winders Davis ◽  
W. David Lohr ◽  
Yana Feygin ◽  
Liza Creel ◽  
Kahir Jawad ◽  
...  
Keyword(s):  
Foster Care ◽  
Low Income ◽  
Secondary Analysis ◽  
The United States ◽  
Prescribing Patterns ◽  
Cross Sectional ◽  
Children In Foster Care ◽  
Metabolic Monitoring ◽  
Concurrent Use ◽  
High Level

Abstract Background The use of antipsychotic medication and psychotropic polypharmacy has increased in the United States over the last two decades especially for children from low-income families and those in foster care. Although attention has been paid to providing greater insight, prescribing patterns remain concerning since there is a lack of evidence related to safety and efficacy. High-level psychotropic polypharmacy has not been described. We aim to compare the use of HLPP for children receiving Medicaid services and those in foster care and identify factors associated with the duration of use of high-level psychotropic polypharmacy. Additionally, we will examine the frequency of laboratory metabolic screening and emergency department, inpatient, and outpatient visits. Methods A cross-sectional, secondary analysis of statewide data describes trends in high-level psychotropic polypharmacy from 2012 to 2017 and the prevalence and predictors of high-level psychotropic polypharmacy duration and resource use in 2017 for all children on Medicaid and those in foster care. High-level psychotropic polypharmacy included concurrent use, at least four classes of medications including an antipsychotic, and at least 30 days duration. Results High-level psychotropic polypharmacy increased from 2012 to 2014 for both groups but stabilized in 2015–2016. Children in foster care showed a slight increase compared to their peers in 2017. There was no association between duration and demographic characteristics or foster care status. Diagnoses predicted duration. Neither group received metabolic monitoring at an acceptable rate. Conclusions Concerning patterns of high-level psychotropic polypharmacy and metabolic monitoring were identified. Cautious use of high-level psychotropic polypharmacy and greater oversight to ensure that these children are receiving comprehensive services like behavioral health, primary care, and primary prevention.

scholarly journals Interstate variation in trends of psychotropic medication use among Medicaid-enrolled children in foster care

2012 ◽  
Vol 34 (8) ◽  
pp. 1492-1499 ◽  
Author(s):  
David Rubin ◽  
Meredith Matone ◽  
Yuan-Shung Huang ◽  
Susan dosReis ◽  
Chris Feudtner ◽  
...  
Keyword(s):  
Foster Care ◽  
Psychotropic Medication ◽  
Medication Use ◽  
Children In Foster Care
Sign in / Sign up

Export Citation Format

Share Document